Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Use of prasugrel and clinical outcomes in African-American patients treated with percutaneous coronary intervention for acute coronary syndromes.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Use of prasugrel and clinical outcomes in African-American patients treated with percutaneous coronary intervention for acute coronary syndromes.
Use of prasugrel and clinical outcomes in African-American patients treated with percutaneous coronary intervention for acute coronary syndromes. Catheter Cardiovasc Interv. 2019 Jul 01; 94(1):53-60.
View in:
PubMed
subject areas
Acute Coronary Syndrome
Acute Coronary Syndrome
African Americans
African Americans
Age Factors
Age Factors
Aged
Aged
Cause of Death
Cause of Death
Comorbidity
Comorbidity
Female
Female
Health Status Disparities
Health Status Disparities
Healthcare Disparities
Healthcare Disparities
Hemorrhage
Hemorrhage
Humans
Humans
Incidence
Incidence
Male
Male
Middle Aged
Middle Aged
Percutaneous Coronary Intervention
Percutaneous Coronary Intervention
Platelet Aggregation Inhibitors
Platelet Aggregation Inhibitors
Prasugrel Hydrochloride
Prasugrel Hydrochloride
Prevalence
Prevalence
Prospective Studies
Prospective Studies
Registries
Registries
Risk Assessment
Risk Assessment
Risk Factors
Risk Factors
Sex Factors
Sex Factors
Stroke
Stroke
Time Factors
Time Factors
Treatment Outcome
Treatment Outcome
United States
United States
authors with profiles
Usman Baber